Chemistry: analytical and immunological testing – Involving an insoluble carrier for immobilizing immunochemicals – Carrier is inorganic
Reexamination Certificate
2011-03-08
2011-03-08
Gabel, Gailene R (Department: 1641)
Chemistry: analytical and immunological testing
Involving an insoluble carrier for immobilizing immunochemicals
Carrier is inorganic
C435S007200, C435S007240, C435S372000, C435S287200, C436S518000, C436S523000, C436S536000, C436S538000, C436S010000, C436S017000, C436S018000, C436S063000, C436S172000, C436S176000, C436S177000, C422S073000, C422S082050, C422S105000
Reexamination Certificate
active
07901950
ABSTRACT:
Elevated number of Circulating Endothelial Cells (CEC) have been implicated in disease conditions associated with the formation or destruction of blood vessels such as acute coronary syndrome, thrombocytopenic purpura, sickle cell disease, sepsis, lupus, nephrotic syndromes, rejection of organ transplants, surgical trauma and cancer. This invention provides a method for assessing the levels of CEC which vary between different studies using a sensitive enrichment, imaging, and enumberation analysis. CD146 is one of the most specific endothelium-associated cell-surface antigens which can be used in image cytometry. CEC analysis provides an essential tool in prognostic/diagnostic evaluation in the clinic.
REFERENCES:
patent: 3970518 (1976-07-01), Giaever
patent: 4018886 (1977-04-01), Giaever
patent: 4230685 (1980-10-01), Senyei et al.
patent: 4267234 (1981-05-01), Rembaum
patent: 4452773 (1984-06-01), Molday
patent: 4554088 (1985-11-01), Whitehead
patent: 4659678 (1987-04-01), Forrest et al.
patent: 4795698 (1989-01-01), Owen
patent: 5200084 (1993-04-01), Liberti et al.
patent: 5597531 (1997-01-01), Liberti et al.
patent: 5698271 (1997-12-01), Liberti et al.
patent: 5876593 (1999-03-01), Liberti et al.
patent: 5985153 (1999-11-01), Dolan et al.
patent: 6136182 (2000-10-01), Dolan et al.
patent: 6184043 (2001-02-01), Fodstad et al.
patent: 6190870 (2001-02-01), Schmitz et al.
patent: 6365362 (2002-04-01), Terstappen et al.
patent: 6645731 (2003-11-01), Terstappen et al.
patent: 6861259 (2005-03-01), Columbus
patent: 6998234 (2006-02-01), Fruehauf et al.
patent: 2004/0110241 (2004-06-01), Segal
patent: 2005/0244897 (2005-11-01), Zeiher et al.
patent: 2004/045517 (2004-06-01), None
patent: 2005/028663 (2005-03-01), None
U.S. Appl. No. 10/780,349, Rao et al., Aug.18, 2005.
U.S. Appl. No. 09/801,471, Leon W.M.M Terstappen et al., May 30, 2001.
U.S. Appl. No. 10/988,057, Richard L. Columbus, Mar. 24, 2005.
U.S. Appl. No. 10/303,309, Kagan et al., Jun. 27, 2004.
Mutin, M. et al, “Direct Evidence of E ndothelial I njury i n Acute Myoc ardial Infarction an d Unstable Angina b y Demonstration of Circulating Endothelial C ells,” Blood, 93:2951-2958, 1999.
Beerepoot, L. et al., “Increased Levels of Viable Circulating Endothelial Cells are an Indicator of Prog ressive Disease i n Canc er Patients,” Ann uls o f Oncology, 15:139-145.2004.
Connelly Mark Carle
Doyle Gerald V.
Rao Galla Chandra
Terstappen Leon W. M. M.
Gabel Gailene R
Veridex, LLC
LandOfFree
Method for assessing disease states by profile analysis of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for assessing disease states by profile analysis of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for assessing disease states by profile analysis of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2705914